FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 301 through 320 of 320

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
TYRA Nasdaq Tyra Biosciences, Inc. 2836
VBIO Nasdaq Valion Bio, Inc. 2836
VCYT Nasdaq Veracyte, Inc. 2836
VERA Nasdaq Vera Therapeutics, Inc. 2836
VIVS Nasdaq VivoSim Labs, Inc. 2836
VOR Nasdaq Vor Biopharma Inc. 2836
VTGN Nasdaq Vistagen Therapeutics, Inc. 2836
VTVT Nasdaq vTv Therapeutics Inc. 2836
VYGR Nasdaq Voyager Therapeutics, Inc. 2836
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2836
XBIT Nasdaq XBiotech Inc. 2836
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2836
XLO Nasdaq Xilio Therapeutics, Inc. 2836
XNCR Nasdaq Xencor, Inc. 2836
XOMA Nasdaq XOMA Royalty Corporation 2836
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2836
ZBIO Nasdaq Zenas BioPharma, Inc. 2836
ZEOX Over the counter Zeo ScientifiX, Inc. 2836
ZLAB Nasdaq Zai Lab Limited 2836
ZNTL Nasdaq Zentalis Pharmaceuticals, Inc. 2836
Results 300 through 320 of 320